Status:
COMPLETED
Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Hot Flashes
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The study was done to elucidate relationships between midlife women's self-reported hot flashes, neuropsychological symptoms, cognitive performance or sleep.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- At least 5 hot flash episodes and/or night sweats per 24 hours
- Exclusion Criteria:
- Body mass index (BMI) more than 34 kg/m2
- Hypertension
- Shift work
- Psychiatric or medical conditions that would affect outcome measures
- More than 4 caffeine drinks per day
- More than 10 cigarettes per day
- More than than 7 alcohol drinks per week
Exclusion
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2001
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT01401946
Start Date
May 1 2000
End Date
January 1 2001
Last Update
July 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham & Women's Hospital
Boston, Massachusetts, United States, 02215